# FDA Inspection 917365 - GP Pharm SA - January 27, 2015

Source: https://www.keypedia.com/records/fda_inspections/gp-pharm-sa/347ba4ad-53b1-4873-9b24-a8180219798f
Source feed: FDA_Inspections

> FDA Inspection 917365 for GP Pharm SA on January 27, 2015. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 917365
- Company Name: GP Pharm SA
- Inspection Date: 2015-01-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1305252 - 2023-09-21](https://www.keypedia.com/records/fda_inspections/gp-pharm-sa/bac0bf28-8173-4b4f-b9ed-6183e90d8314)
- [FDA Inspection 1149441 - 2020-10-02](https://www.keypedia.com/records/fda_inspections/gp-pharm-sa/69cd8789-02cb-4225-8f6f-a4381cfda71c)
- [FDA Inspection 1004446 - 2017-01-24](https://www.keypedia.com/records/fda_inspections/gp-pharm-sa/d67f0658-9a83-4622-a757-b6a1542990ad)

Company: https://www.keypedia.com/companies/gp-pharm-sa/dc9c0e23-15fc-4984-99e1-68b6e5ad0899

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c